ASX Share rice
Sat 19 Jun 2021 - 10:06:am (Sydney)

RVS Share Price

REVASUM INC.RVSSemiconductors & Semiconductor Equipment

RVS Company Information

Name:

Revasum, Inc

Sector:

Technology

Industry:

Semiconductor Equipment & Materials

Address:

825 Buckley Road San Luis Obispo CA United States 93401

Phone:

805 541 6424

Chief Financial & Operating Officer and Company Sec.:

Ms. Rebecca Shooter-Dodd

Acting Chief Technology Officer:

Mr. Bill Kalenian

VP of Worldwide Sales & Marketing:

Mr. Chris Sloan

Company Overview:

Revasum, Inc. designs, develops, manufactures, and markets a portfolio of semiconductor processing equipment in Asia, North America, and Europe. The company offers grinding, polishing, and chemical mechanical planarization equipment to manufacture microchips, sensors, LEDs, and RF and power devices, which are used in IoT devices, cellphones, wearables, automotive, and 5G and industrial applications. It also provides wafer processing equipment for device and substrate manufacturing; and spare parts kits, on-site and off-site training, and training services. The company was founded in 2016 and is headquartered in San Luis Obispo, California.

RVS Share Price Information

Shares Issued:

105.63M

Market Capitalisation:

$33.80M

Revenue (TTM):

$15.37M

Revenue Per Share (TTM):

$0.20

Earnings per Share:

$-0.134

Profit Margin:

-0.5958

Operating Margin (TTM):

$-0.39

Return On Assets (TTM):

$-0.14

Return On Equity (TTM):

$-0.55

Quarterly Revenue Growth (YOY):

0.666

Gross Profit(TTM):

$4.89M

Diluted Earnings Per Share (TTM):

$-0.152

RVS CashFlow Statement

CashFlow Date:

2020-12-31

Investments:

$-672,552.58

Change To Liabilities:

$-3,653,000

Total Cashflow From Investing Activities:

$-518,000

Net Borrowings:

$506K

Net Income:

$-11,887,821.35

Total Cash From Operating Activities:

$-5,493,000

Depreciation:

$563.49K

Change To Inventory:

$3.37M

Change To Account Receivables:

$-944,000

Sale Purchase Of Stock:

$31K

Capital Expenditures:

$672.55K

RVS Income Statement

Income Date:

2020-12-31

Income Before Tax:

$-11,887,821.35

Net Income:

$-11,887,821.35

Gross Profit:

$6.35M

Operating Income:

$-7,726,564.53

Interest Expense:

$311.61K

Total Revenue:

$19.95M

Total Operating Expenses:

$14.07M

Cost Of Revenue:

$13.61M

RVS Balance Sheet

Balance Sheet Date:

2020-12-31

Intangible Assets:

$4.92M

Total Liabilities:

$10.65M

Total Stockholder Equity:

$15.57M

Other Current Liabilities:

$440K

Total Assets:

$26.21M

Common Stock:

$43.61M

Other Current Assets:

$38K

Retained Earnings:

$-42,381,199.69

Other Assets:

$3.85M

Cash:

$1.77M

Total Current Liabilities:

$7.87M

Short-Term Debt:

$3.25M

Property - Plant & Equipment:

$5.02M

Net Tangible Assets:

$11.99M

Total Current Assets:

$14.69M

Long-Term Debt:

$0.94M

Net Receivables:

$3.59M

Short-Term Investments:

$11.52M

Inventory:

$8.83M

Accounts Payable:

$1.54M

Non Currrent Assets (Other):

$76.60K

Short-Term Investments:

$11.52

Non Current Liabilities Total:

$2.78M

RVS Share Price History

RVS News

02 Jun, 2021
Global semiconductor technology and equipment firm Revasum, Inc. (ASX: RVS, 'Revasum' or 'the Company') is pleased to announce it has secured the first purchase order for two 6EZ Silicon Carbide (SiC) Polishers from a NASDAQ-listed major global semiconductor wafer manufacturer. The first tool will ship to the customer's European facility in August 2021, followed by the delivery of a second tool during the first half of 2022. The customer is also forecasting requirements for additional tools duri
21 May, 2021
SAN JOSE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of April 30, 2021, were IntraOp Medical, Wrightspeed, Pivotal Systems, Revasum, and Hera Systems. 1.IntraOp Medical Corp. is the manufacturer of the Mobetron, a medical device that is used to deliver intra-operative radiation to cancer patients. As of April 30, 2021, the Fund’s investment in IntraOp consisted of 26,856,187 shares of preferred stock plus debt securities and represented approximately 25.3% of the Fund’s estimated total investments.* 2.Wrightspeed, Inc. is a supplier of electric drivetrains for heavy-duty commercial vehicles. As of April 30, 2021, the Fund’s investment in Wrightspeed consisted of 60,802,795 shares of preferred and common stock plus debt securities and warrants to purchase additional shares, and represented approximately 23.4% of the Fund’s estimated total investments.* 3.Pivotal Systems Corp. (ASX: PVS) provides monitoring and process control technologies for the semiconductor manufacturing industry. As of April 30, 2021, the Fund’s investment in Pivotal consisted of 23,089,506 shares of common stock equivalents (CDI’s) and represented approximately 23.1% of the Fund’s estimated total investments.* 4.Revasum, Inc. (ASX: RVS) is a provider of chemical-mechanical planarization (CMP) and grinding tools to the semiconductor industry. As of April 30, 2021, the Fund’s investment in Revasum consisted of 46,834,340 shares of common stock equivalents (CDI’s) and represented approximately 12.0% of the Fund’s estimated total investments.* 5.Hera Systems, Inc. is developing micro satellites with imaging and communication capabilities for launch into low Earth orbit. As of April 30, 2021, the Fund’s investment in Hera consisted of 13,331,527 shares of preferred stock plus debt securities and warrants to purchase additional shares and represented approximately 3.3% of the Fund’s estimated total investments.* The Fund also announced that as of April 30, 2021, the estimated total investments* of the Fund were approximately $118 million, or $17.15 per share, including cash and cash equivalents of approximately $0.95 per share. As of that date, the Fund’s top five holdings constituted 87.0% of the Fund’s estimated total investments.* Complete financial statements and a detailed schedule of investments as of June 30, 2021, will be available in the Fund’s quarterly report filing on Form 10-Q in August 2021. *Total investments are estimated as of April 30, 2021, and represent the value of the Fund’s total investments as of March 31, 2021, plus the estimated net change in unrealized appreciation/depreciation and actual realized gains/losses on publicly traded and private securities since March 31, 2021. For the purposes of calculating the percentage of estimated total investments represented by each investment, the value of each holding is determined by either: (1) the purchase price, (2) the market value for public securities, less any discounts taken due to restrictions on the stock, or (3) the March 31, 2021, fair value of each security, as determined under procedures approved by our Board of Directors. The estimated total investments figure does not reflect net asset value because actual and estimated liabilities (such as estimated tax liabilities and performance fees, accrued vendor service fees and other liabilities) are not deducted. About Firsthand Technology Value Fund Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies. More information about the Fund and its holdings can be found online at www.firsthandtvf.com. The Fund is a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund’s investment objective is to seek long-term growth of capital. Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies. An investment in the Fund involves substantial risks, some of which are highlighted below. Unlike most business development companies, the Fund is taxed as a corporation rather than a Regulated Investment Company under federal tax laws, based on the composition of its assets. Please see the Fund’s public filings for more information about fees, expenses and risk. Past investment results do not provide any assurances about future results. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to materially differ from the Fund’s historical experience and its present expectations or projections indicated in any forward-looking statement. These risks include, but are not limited to, changes in economic and political conditions, regulatory and legal changes, technology and cleantech industry risk, valuation risk, non-diversification risk, interest rate risk, tax risk, and other risks discussed in the Fund’s filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund’s investment objectives will be attained. We acknowledge that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as us. Contact: Phil Mosakowski Firsthand Capital Management, Inc. (408) 624-9526 vc@firsthandtvf.com
29 Apr, 2021
Top Holdings Include Pivotal Systems, IntraOp Medical, Wrightspeed, Revasum, and Hera SystemsSAN JOSE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of March 31, 2021, was $16.31. The Fund further announced that its top five holdings as of March 31, 2021, were Pivotal Systems, IntraOp Medical, Wrightspeed, Revasum, and Hera Systems. Pivotal Systems Corp. (ASX: PVS) provides monitoring and process control technologies for the semiconductor manufacturing industry. As of March 31, 2021, the Fund’s investment in Pivotal consisted of 31,089,506 shares of common stock equivalents (CDI’s) and represented approximately 27.3% of the Fund’s preliminary net assets.IntraOp Medical Corp. is the manufacturer of the Mobetron, a medical device that is used to deliver electron-based radiation to cancer patients. As of March 31, 2021, the Fund’s investment in IntraOp consisted of 26,856,187 shares of preferred stock plus debt securities and represented approximately 25.7% of the Fund’s preliminary net assets.Wrightspeed, Inc. is a supplier of electric drivetrains for heavy-duty trucks. As of March 31, 2021, the Fund’s investment in Wrightspeed consisted of 60,802,795 shares of preferred and common stock plus debt securities and warrants to purchase additional shares and represented approximately 23.6% of the Fund’s preliminary net assets.Revasum, Inc. (ASX: RVS) is a provider of chemical-mechanical planarization (CMP) and grinding tools to the semiconductor industry. As of March 31, 2021, the Fund’s investment in Revasum consisted of 46,834,340 shares of common stock equivalents (CDI’s) and represented approximately 11.2% of the Fund’s preliminary net assets.Hera Systems, Inc. is developing micro satellites with imaging and communication capabilities for launch into low Earth orbit. As of March 31, 2021, the Fund’s investment in Hera consisted of 13,331,527 shares of preferred stock plus debt securities and warrants to purchase additional shares and represented approximately 3.3% of the Fund’s preliminary net assets. The Fund’s preliminary net assets as of March 31, 2021, include cash and cash equivalents of approximately $0.07 per share. Preliminary total investments as of March 31, 2021 were $111.2 million, or approximately $16.14 per share. As of March 31, 2021, the Fund’s top five holdings constituted 91.1% of the Fund’s preliminary net assets, and 91.7% of our preliminary total investments. The Fund’s NAV for March 31, 2021, as well as complete financial statements and a detailed schedule of investments, will be made available with the Fund’s quarterly report filing on Form 10-Q in May 2021. About Firsthand Technology Value Fund Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies. More information about the Fund and its holdings can be found online at www.firsthandtvf.com. The Fund is a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund’s investment objective is to seek long-term growth of capital. Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies. An investment in the Fund involves substantial risks, some of which are highlighted below. Please see the Fund’s public filings for more information about fees, expenses and risk. Past investment results do not provide any assurances about future results. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to materially differ from the Fund’s historical experience and its present expectations or projections indicated in any forward-looking statement. These risks include, but are not limited to, changes in economic and political conditions, regulatory and legal changes, technology and cleantech industry risk, valuation risk, non-diversification risk, interest rate risk, tax risk, and other risks discussed in the Fund’s filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund’s investment objectives will be attained. We acknowledge that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as us. Contact: Phil Mosakowski Firsthand Capital Management, Inc. (408) 624-9526 vc@firsthandtvf.com
25 Jan, 2021
Top Holdings Include IntraOp Medical, Wrightspeed, Pivotal Systems, Revasum, and SVXRSAN JOSE, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of December 31, 2020, was $14.82. The Fund further announced that its top five holdings as of December 31, 2020, were IntraOp Medical, Wrightspeed, Pivotal Systems, Revasum, and SVXR. 1.IntraOp Medical Corp. is the manufacturer of the Mobetron, a medical device that is used to deliver electron-based radiation to cancer patients. As of December 31, 2020, the Fund’s investment in IntraOp consisted of 26,856,187 shares of preferred stock plus debt securities and represented approximately 25.8% of the Fund’s preliminary net assets. 2.Wrightspeed, Inc. is a supplier of electric drivetrains for heavy-duty trucks. As of December 31, 2020, the Fund’s investment in Wrightspeed consisted of 60,802,795 shares of preferred and common stock plus debt securities and warrants to purchase additional shares and represented approximately 23.1% of the Fund’s preliminary net assets. 3.Pivotal Systems Corp. (ASX: PVS) provides monitoring and process control technologies for the semiconductor manufacturing industry. As of December 31, 2020, the Fund’s investment in Pivotal consisted of 31,089,506 shares of common stock equivalents (CDI’s) and represented approximately 22.1% of the Fund’s preliminary net assets. 4.Revasum, Inc. (ASX: RVS) is a provider of chemical-mechanical planarization (CMP) and grinding tools to the semiconductor industry. As of December 31, 2020, the Fund’s investment in Revasum consisted of 46,834,340 shares of common stock equivalents (CDI’s) and represented approximately 12.4% of the Fund’s preliminary net assets. 5.SVXR, Inc. is a manufacturer of automated X-ray inspection tools for the semiconductor and microelectronics industries. As of December 31, 2020, the Fund’s investment in SVXR consisted of 8,219,454 shares of preferred stock and represented approximately 5.3% of the Fund’s preliminary net assets. The Fund’s preliminary net assets as of December 31, 2020, include cash and cash equivalents of approximately $0.34 per share. Preliminary total investments as of December 31, 2020 were $99.7 million, or approximately $14.46 per share. As of December 31, 2020, the Fund’s top five holdings constituted 88.7% of the Fund’s preliminary net assets, and 88.7% of our preliminary total investments. The Fund’s NAV for December 31, 2020, as well as complete financial statements and a detailed schedule of investments, will be made available with the Fund’s annual report filing on Form 10-K in March 2021. About Firsthand Technology Value Fund Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies. More information about the Fund and its holdings can be found online at www.firsthandtvf.com. The Fund is a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund’s investment objective is to seek long-term growth of capital. Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies. An investment in the Fund involves substantial risks, some of which are highlighted below. Please see the Fund’s public filings for more information about fees, expenses and risk. Past investment results do not provide any assurances about future results. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to materially differ from the Fund’s historical experience and its present expectations or projections indicated in any forward-looking statement. These risks include, but are not limited to, changes in economic and political conditions, regulatory and legal changes, technology and cleantech industry risk, valuation risk, non-diversification risk, interest rate risk, tax risk, and other risks discussed in the Fund’s filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund’s investment objectives will be attained. We acknowledge that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as us. Contact: Phil Mosakowski Firsthand Capital Management, Inc. (408) 624-9526 vc@firsthandtvf.com
24 Nov, 2020
With the business potentially at an important milestone, we thought we'd take a closer look at Revasum, Inc.'s...
23 Oct, 2020
Top Holdings Include Pivotal Systems, IntraOp Medical, Wrightspeed, Revasum, and SVXRSAN JOSE, Calif., Oct. 23, 2020 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its preliminary NAV, as of September 30, 2020, was $13.81. The Fund further announced that its top five holdings as of September 30, 2020, were Pivotal Systems, IntraOp Medical, Wrightspeed, Revasum, and SVXR. 1.Pivotal Systems Corp. (ASX: PVS) provides monitoring and process control technologies for the semiconductor manufacturing industry. As of September 30, 2020, the Fund’s investment in Pivotal consisted of 38,090,506 shares of common stock equivalents (CDI’s) and represented approximately 30.7% of the Fund’s preliminary net assets. 2.IntraOp Medical Corp. is the manufacturer of the Mobetron, a medical device that is used to deliver intra-operative radiation to cancer patients. As of September 30, 2020, the Fund’s investment in IntraOp consisted of 26,856,187 shares of preferred stock plus debt securities and represented approximately 23.3% of the Fund’s preliminary net assets. 3.Wrightspeed, Inc. is a supplier of electric drivetrains for medium-duty trucks. As of September 30, 2020, the Fund’s investment in Wrightspeed consisted of 60,802,795 shares of preferred and common stock plus debt securities and warrants to purchase additional shares and represented approximately 19.8% of the Fund’s preliminary net assets. 4.Revasum, Inc. (ASX: RVS) is a provider of chemical-mechanical planarization (CMP) and grinding tools to the semiconductor industry. As of September 30, 2020, the Fund’s investment in Revasum consisted of 46,834,340 shares of restricted and unrestricted common stock and common stock equivalents and represented approximately 8.0% of the Fund’s preliminary net assets. 5.SVXR, Inc. is a manufacturer of automated X-ray inspection tools for the semiconductor and microelectronics industries. As of September 30, 2020, the Fund’s investment in SVXR consisted of 8,219,454 shares of preferred stock and represented approximately 5.6% of the Fund’s preliminary net assets. The Fund’s preliminary net assets as of September 30, 2020, include cash and cash equivalents of approximately $0.34 per share. Preliminary total investments as of September 30, 2020 were $95.5 million, or approximately $13.85 per share. As of September 30, 2020, the Fund’s top five holdings constituted 87.3% of the Fund’s preliminary net assets, and 87.1% of our preliminary total investments. The Fund’s NAV for September 30, 2020, as well as complete financial statements and a detailed schedule of investments, will be made available with the Fund’s quarterly report filing on Form 10-Q in November 2020.About Firsthand Technology Value Fund Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies. More information about the Fund and its holdings can be found online at www.firsthandtvf.com.The Fund is a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund’s investment objective is to seek long-term growth of capital. Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies. An investment in the Fund involves substantial risks, some of which are highlighted below. Please see the Fund’s public filings for more information about fees, expenses and risk. Past investment results do not provide any assurances about future results. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to materially differ from the Fund’s historical experience and its present expectations or projections indicated in any forward-looking statement. These risks include, but are not limited to, changes in economic and political conditions, regulatory and legal changes, technology and cleantech industry risk, valuation risk, non-diversification risk, interest rate risk, tax risk, and other risks discussed in the Fund’s filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund’s investment objectives will be attained. We acknowledge that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as us.Contact:Phil Mosakowski Firsthand Capital Management, Inc. (408) 624-9526 vc@firsthandtvf.com